Tranexamic acid for cesarean section: A double-blind, placebo-controlled, randomized clinical trial

Archives of Gynecology and Obstetrics

Volumn 287, Issue 4, 2013, Pages 641-645

  Sentürk, Mehmet B ^a   Cakmak, Yusuf ^a   Yildiz, Gazi ^b   Yildiz, Pinar ^b  

^a Laboratories of Batman Maternity and Children s Hospital   (Turkey)

^b Bucak State Hospital   (Turkey)

Author keywords

Bleeding; Cesarean; Postpartum; Thrombosis; Tranexamic acid

Indexed keywords

PLACEBO; TRANEXAMIC ACID;

ARTICLE; CESAREAN SECTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GESTATIONAL AGE; HUMAN; INTRAPARTUM HEMORRHAGE; NORMAL HUMAN; POSTPARTUM HEMORRHAGE; VENOUS THROMBOEMBOLISM;

ADULT; ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; CESAREAN SECTION; DOUBLE-BLIND METHOD; FEMALE; HEMATOLOGIC TESTS; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; TRANEXAMIC ACID; YOUNG ADULT;

EID: 84876675090     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2624-8     Document Type: Article

References (24)

1. Gungorduk K, YIldIrIm G (2011) Efficacy of Intravenous Tranexamic acid in reducing blood loss after elective caesarean section: A prospective, randomized, double-blindplacebo-Controlled Study. Am J Perinatol 28(3):233-240
2. Magann EF, Evans S, Hutchinson M, Collins R, Lanneau G, Morrison JC (2005) Postpartum hemorrhage after caesarean delivery: An analysis of risk factors. South Med J 98(7):681-685 (Pubitemid 41061652)
3. Hogan MC, Foreman KJ, Naghavi M, Ahn SY, Wang M, Makela SM, Lopez AD, Lozano R, Murray CJ (2010) Maternal mortality for 181 countries, 1980-2008: A systematic analysis of progress towards millennium development goal 5. Lancet 375(9726):1609-1623
4. Ronsmans C, Graham WJ (2006) Maternal mortality: who, when, where, and why. Lancet 368(9542):1189-1200 (Pubitemid 44441554)
5. AbouZahr C (2003) Global burden of maternal death and disability. Br Med Bull 67:1-11 (Pubitemid 38111987)
6. Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC (2001) Comparison of two oxytocin regimens to prevent uterine atony at caesarean delivery: A randomized controlled trial. Obstet Gynecol 98(3):386-390 (Pubitemid 32889568)
7. Sekhavat L, Tabatabaii A, Dalili M, Farajkhoda T, Tafti AD (2009) Efficacy of tranexamic acid in reducing blood loss after caesarean section. J Matern Fetal Neonatal Med 22(1):72-75
8. Shakur H, Elbourne D, Gülmezoglu M, Alfirevic Z, Ronsmans C, Allen E, Roberts I (2010) The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: An international randomised, double blind placebo controlled trial. Trials 16(11):40
9. Peitsidis P, Kadir RA (2011) Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum. Expert Opin Pharmacother 12(4):503-516
10. Gleeson NC, Buggy F, Sheppard BL, Bonnar J (1994) The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding. Acta Obstet Gynecol Scand 73(3):274-277 (Pubitemid 24074449)
11. Rath W, Hackethal A, Bohlmann MK (2012) Second-line treatment of postpartum haemorrhage. Arch Gynecol Obstet 286(3):549-561
12. Gai MY, Wu LF, Su QF, Tatsumoto K (2004) Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: A multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol 112(2):154-157 (Pubitemid 38117331)
13. Cook L, Roberts I, WOMAN Trial Collaborators (2010) Post-partum haemorrhage and the WOMAN trial. Int J Epidemiol 39(4):949-950
14. Stafford I, Dildy GA, Clark SL, Belfort MA (2008) Visually estimated and calculated blood loss in vaginal and caesarean delivery. Am J Obstet Gynecol 199(5):519
15. Gohel M, Patel P, Gupta A, Desai P (2007) Efficacy of tranexamic acid in decreasing blood loss during and after caesarean section: A randomized case controlled prospective study. J Obstet Gynecol India 57:227-230
16. Gherman RB, Goodwin TM, Leung B, Byrne JD, Montoro M (1998) Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Prim Care Update Ob Gyns 5(4):155-156
17. Toglia MR, Weg JG (1996) Venous thromboembolism during pregnancy. N Engl J Med 335(2):108-114 (Pubitemid 26240113)
18. Shakur H, Roberts I et al (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet 376(9734):23-32
19. Caglar GS, Tasci Y, Kayikcioglu F, Haberal A (2008) Intravenous tranexamic acid use in myomectomy: A prospective randomized double-blind placebo controlled study. Eur J Obstet Gynecol Reprod Biol 137(2):227-231 (Pubitemid 351423454)
20. Sundström A, Seaman H, Kieler H, Alfredsson L (2009) The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: A case-control study using the General Practice Research Database. BJOG 116(1):91-97
21. Taparia M, Cordingley FT, Leahy MF (2002) Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia. Eur J Haematol 68(5):307-309
22. Imbesi S, Nettis E, Minciullo PL, Di Leo E, Saija A, Vacca A, Gangemi S (2010) Hypersensitivity to tranexamic acid: A wide spectrum of adverse reactions. Pharm World Sci 32(4):416-419
23. Schulz KF, Altman DG, Moher D (2010) CONSORT Group CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials BMJ 340:332
24. Molenaar IQ, Warnaar N, Groen H, Tenvergert EM, Slooff MJ, Porte RJ (2007) Efficacy and safety of antifibrinolytic drugs in liver transplantation: A systematic review and meta-analysis. Am J Transplant 7(1):185-194 (Pubitemid 44952872)